The marine biodiscovery pipeline and ocean medicines of tomorrow

Marcel Jaspars; Donatella De Pascale; Jeanette H. Andersen; Fernando Reyes; Alexander D. Crawford; Adrianna Ianora

doi:10.1017/S0025315415002106

The marine biodiscovery pipeline and ocean medicines of tomorrow

Marcel Jaspars, Donatella De Pascale, Jeanette H. Andersen, Fernando Reyes, Alexander D. Crawford, Adrianna Ianora^*

^*Corresponding author for this work

Chemistry

Research output: Contribution to journal › Article › peer-review

112 Citations (Scopus)

Abstract

Marine organisms possess the capacity to produce a variety of unique and biologically potent natural products for treating human diseases, many of which are currently commercially available or are in advanced clinical trials. Here we provide a short review on progress in the field and discuss a case study of an EU-funded project, PharmaSea, which aims to discover novel products for the treatment of infections, inflammation and neurodegenerative diseases. Research in this sector is opening new doors for harnessing the potential of marine natural products with pharmaceutical properties.

Original language	English
Pages (from-to)	151-158
Number of pages	8
Journal	Journal of the Marine Biological Association of the United Kingdom
Volume	96
Issue number	1
Early online date	19 Jan 2016
DOIs	https://doi.org/10.1017/S0025315415002106
Publication status	Published - Feb 2016

Keywords

drug discovery
ocean medicines
PharmaSea project
natural-products
clinical-trials
pain
framework
systems
sponge

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1017/S0025315415002106Licence: Unspecified

Cite this

@article{13e84acfcc114f53b41c6da48feda411,

title = "The marine biodiscovery pipeline and ocean medicines of tomorrow",

abstract = "Marine organisms possess the capacity to produce a variety of unique and biologically potent natural products for treating human diseases, many of which are currently commercially available or are in advanced clinical trials. Here we provide a short review on progress in the field and discuss a case study of an EU-funded project, PharmaSea, which aims to discover novel products for the treatment of infections, inflammation and neurodegenerative diseases. Research in this sector is opening new doors for harnessing the potential of marine natural products with pharmaceutical properties.",

keywords = "drug discovery, ocean medicines, PharmaSea project, natural-products, clinical-trials, pain, framework, systems, sponge",

author = "Marcel Jaspars and {De Pascale}, Donatella and Andersen, {Jeanette H.} and Fernando Reyes and Crawford, {Alexander D.} and Adrianna Ianora",

year = "2016",

month = feb,

doi = "10.1017/S0025315415002106",

language = "English",

volume = "96",

pages = "151--158",

journal = "Journal of the Marine Biological Association of the United Kingdom",

issn = "0025-3154",

publisher = "Cambridge University Press",

number = "1",

}

TY - JOUR

T1 - The marine biodiscovery pipeline and ocean medicines of tomorrow

AU - Jaspars, Marcel

AU - De Pascale, Donatella

AU - Andersen, Jeanette H.

AU - Reyes, Fernando

AU - Crawford, Alexander D.

AU - Ianora, Adrianna

PY - 2016/2

Y1 - 2016/2

N2 - Marine organisms possess the capacity to produce a variety of unique and biologically potent natural products for treating human diseases, many of which are currently commercially available or are in advanced clinical trials. Here we provide a short review on progress in the field and discuss a case study of an EU-funded project, PharmaSea, which aims to discover novel products for the treatment of infections, inflammation and neurodegenerative diseases. Research in this sector is opening new doors for harnessing the potential of marine natural products with pharmaceutical properties.

AB - Marine organisms possess the capacity to produce a variety of unique and biologically potent natural products for treating human diseases, many of which are currently commercially available or are in advanced clinical trials. Here we provide a short review on progress in the field and discuss a case study of an EU-funded project, PharmaSea, which aims to discover novel products for the treatment of infections, inflammation and neurodegenerative diseases. Research in this sector is opening new doors for harnessing the potential of marine natural products with pharmaceutical properties.

KW - drug discovery

KW - ocean medicines

KW - PharmaSea project

KW - natural-products

KW - clinical-trials

KW - pain

KW - framework

KW - systems

KW - sponge

U2 - 10.1017/S0025315415002106

DO - 10.1017/S0025315415002106

M3 - Article

SN - 0025-3154

VL - 96

SP - 151

EP - 158

JO - Journal of the Marine Biological Association of the United Kingdom

JF - Journal of the Marine Biological Association of the United Kingdom

IS - 1

ER -

The marine biodiscovery pipeline and ocean medicines of tomorrow

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this